bioAffinity Technologies Files 10-K Amendment

Ticker: BIAFW · Form: 10-K/A · Filed: Apr 29, 2025 · CIK: 1712762

Sentiment: neutral

Topics: amendment, annual-report, research

Related Tickers: BIAF

TL;DR

BIAF filed a 10-K/A for FY24. Check for updates.

AI Summary

bioAffinity Technologies, Inc. filed an amendment (Amendment No. 1) to its annual report on Form 10-K for the fiscal year ended December 31, 2024. The company, incorporated in Delaware with its principal business address in San Antonio, TX, is engaged in commercial physical and biological research.

Why It Matters

This filing provides updated information for the fiscal year 2024, which is crucial for investors to assess the company's financial health and operational status.

Risk Assessment

Risk Level: medium — As a company filing an amendment to its annual report, there may be significant updates or corrections that could impact its valuation.

Key Numbers

Key Players & Entities

FAQ

What specific information is being amended in this 10-K filing?

The filing is an Amendment No. 1 to the Form 10-K for the fiscal year ended December 31, 2024, indicating updates or corrections to the original report.

What is the primary business of bioAffinity Technologies, Inc.?

The company is involved in 'SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH' with SIC code 8731.

Where is bioAffinity Technologies, Inc. headquartered?

The company's business and mailing address is 3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TX 78217.

What is the SEC file number for bioAffinity Technologies, Inc.?

The SEC file number is 001-41463.

When was this amendment filed?

This amendment was filed on April 29, 2025.

Filing Details

This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 29, 2025 regarding bioAffinity Technologies, Inc. (BIAFW).

View full filing on EDGAR

View Full Filing

View this 10-K/A filing on SEC EDGAR

View on Read The Filing